Comparison of the Efficacy and Safety of S-1-Based and Capecitabine-Based Regimens in Gastrointestinal Cancer: A Meta-Analysis

• Xunlei Zhang,

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯
• Chunxiang Cao,

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯
• Qi Zhang,

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯
• Yi Chen,

  Affiliation Department of Oncology, Nanjing First Hospital, Medical School of Southeast University, Nanjing, China

  ⨯
• Dongying Gu,

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯
• Yunzhu Shen,

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯
• Yongling Gong,

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯
• Jinfei Chen,

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯
• Cuiju Tang

  * E-mail: tangcuiju@tom.com

  Affiliation Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China

  ⨯